Tumor angiogenesis is regulated by CXC chemokines

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 2, 1998, Pages 97-103

  Moore, Bethany B ^a   Arenberg, Douglas A ^a   Addison, Christina L ^a   Keane, Michael P ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032146676     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90004-X     Document Type: Conference Paper

References (69)

1. Folkman J, Cotran R. Relation of vascular proliferation to rumor growth. Int Rev Exp Pathol 1976;16:207-48.
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
3. Folkman J, Brem H. Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. 2nd ed. New York: Raven Press, 1992:821-39.
4. Folkman J. Tumor angiogenesis. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weischelbaum RR, editors. Cancer medicine (vol I). 3rd ed. Philadelphia: Lea & Febiger, 1993:153-70.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
6. Polverini PJ, Cotran PS, Gimbrone MA, Unanue ER. Activated macrophages induce vascular proliferation. Nature(London) 1977;269:804-6.
7. Polverini PJ. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer 1996;32A:2430-7.
8. Leibovich SJ, Weisman DM. Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 1988;266:131-45.
9. Auerbach R. Angiogenesis-inducing factors: a review. In: Lymphokines (vol 69). New York: Academic Press, 1981.
10. Gamble JR, Matthias U, Meyer G. Regulation of in vitro capillary tube formation by antiintegrin antibodies. J Cell Biol 1993;121:921-43.
11. Konerding MA, VanAckern C, Steinberg F, Streffer C. Combined morphological approaches in the study of network formation in tumor angiogenesis. Angiogenesis: key principles. Basel: Birkhauser Verlag, 1992:40-58.
12. Paweletz N, Knierim M. Tumor-related angiogenesis. Crit Rev Oncol Hematol 1989;9:197-242.
13. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 1995;210:51-7.
14. Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348-57.
15. Strieter RM, Kunkel SL, Shanafelt AB, Arenberg DA, Koch AE, Polverini PJ. CXC chemokines in regulation of angiogenesis. In: Koch AE, Strieter RM, editors. Chemokines in disease. Austin, TX: RG Landes, 1996:195-210.
16. Walz A, Kunkel SL, Strieter RM. CXC chemokines: an overview. In: Koch AE, Strieter RM, editors. Chemokines in disease. Austin, TX: RG Landes, 1996:1-26.
17. Strieter RM, Kunkel SL. Chemokines and the lung. In: Crystal R, West J, Weibel E, Barnes P, editors. Lung: scientific foundations. 2nd ed. NY: Raven Press, 1997:155-86.
18. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL. Cytokines and lung inflammation. Thorax 1993;48:765-9.
19. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
20. Baggiolini M, Dewald B, Walz A. Interleukin-8 and related chemotactic cytokines. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1992.
21. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989;1:2-13.
22. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
23. Taub DD, Oppenheim JJ. Chemokines, inflammation and immune system. Ther Immunol 1994;1:229-46.
24. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997;61:246-57.
25. Rollins BJ. Chemokines. Blood 1997;90:909-28.
26. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-33.
27. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
28. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-3.
29. Shirozu M, Nakano T, Inazawa J, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics 1995;28:495-500.
30. Maione TE, Gray GS, Petro J, et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247:77-9.
31. Maione TE, Gray GS, Hunt AJ, Sharpe RJ. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res 1991;51:2077-83.
32. Hansell P, Maione TE, Borgstrom P. Selective binding of platelet factor 4 to regions of active angiogenesis in vivo. Am J Physiol 1995;269:H829-36.
33. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 1990;82:848-53.
34. Strieter RM, Kunkel SL, Elner VM, et al. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992;141:1279-84.
35. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
36. Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Strieter RM. In vitro and in vivo systems to assess the role of CXC chemokines in the regulation of angiogenesis. Methods Enzymol 1997;283:190-220.
37. Bouck N. Tumor angiogenesis: the role of oncogenes and rumor suppressor genes. Cancer Cells 1990;2:179-85.
38. Bouck N. Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis. Cancer Treat Res 1992;63:359-71.
39. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
40. Maiorana A, Gullino PM. Acquisition of angiogeni'c capacity and neoplastic transformation in the rat mammary gland. Cancer Res 1978;38:4409-14.
41. Herlyn M, Clark WH, Rodeck U, Manciati ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987;56:461-74.
42. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
43. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
44. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
45. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992;340:145-6.
46. Smith DR, Polverini PJ, Kunkel SL, et al. Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994;179:1409-15.
47. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. Inhibition of interleukin-8 reduces tumori-genesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996;97:2792-802.
48. Arenberg DA, Kunkel SL, Polverini PJ, et al. Interferon - inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumori-genesis and spontaneous metastases. J Exp Med 1996;184:981-92.
49. Luan J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma minor progression. J Leukoc Biol 1997;62:588-97.
50. Kitadai Y, Haruma K, Sumii K, et al. Expression of Interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998;152:93-100.
51. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP 10 and mig: structure, function, and expression in activated T lymphocytes. J Exp Med 1996;184:963-9.
52. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nature Med 1996;2:1174-8.
53. Schönbeck U, Brandt E, Petersen F, Flad H, Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995;154:2375-83.
54. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-7.
55. Hadley TJ, Lu Z, Wasniöwska K, Peiper SC, Hesselgesser J, Horuk R. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy bloodgroup antigen. J Clin Invest 1994;94:985-91.
56. Neote K, Darbonne W, Ogez J, Horuk R, Schall T. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993;268:985-91.
57. Nanney LB, Mueller SG, Bueno R, Peiper SC, Richmond A. Distributions of melanoma growth stimulatory activity or growth-related gene and the interleukin-8 receptor type B in human wound repair. Am J Pathol 1995;147:1248-60.
58. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997;385:347-50.
59. Bais c, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene, and angiogenesis activator. Nature 1998;391:86-9.
60. Boshoff C. Coupling herpesvirus to angiogenesis. Nature 1998;391:24-5.
61. Boshoff C, Endo Y, Collins PD, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997;278:290-4.
62. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-44.
63. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
64. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity B-cell lymphoma. N Engl J Med 1995;335:1186-91.
65. Boshoff C, Weiss RA. Kaposi's sarcoma associated herpesvirus. Curr Opin Infect Dis 1997;10:26-31.
66. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1997;93:14862-7.
67. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma associated herpesvirus (HHV-8) in culture. Nat Med 1996;2:342-6.
68. Mesri EA, Cesarman E, Arvanitakes L, Fafii S, Moore MA, Posnett DN, et al. Human herpesvirus-8/Kaposi's sarcoma-acssociated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996;183:2385-90.
69. Luster AD, Greenberg SM, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995;182:219-32.